Author:
Robillard N,Wuillème S,Lodé L,Magrangeas F,Minvielle S,Avet-Loiseau H
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference8 articles.
1. Robillard N, Avet-Loiseau H, Garand R, Moreau P, Pineau D, Rapp MJ et al. CD20 is associated with a small mature plasma-cell morphology and t(11;14) in multiple myeloma. Blood 2003; 102: 1070–1071.
2. Linenberger ML . CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance. Leukemia 2005; 19: 176–182.
3. Sievers EL, Larson RA, Stadtmauer EA, Estey E, Löwenberg B, Dombret H, for the Mylotarg Study Group. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse. J Clin Oncol 2001; 19: 3244–3254.
4. Ocqueteau M, Orfao A, Almeida J, Blade J, Gonzalez M, Garcia-Sanz R et al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol 1998; 152: 1655–1665.
5. Epstein J, Xiao HQ, He XY . Markers of multiple hematopoietic-cell lineages in multiple myeloma. N Engl J Med 1990; 322: 664–668.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献